Home > Boards > US Listed > Medical - Healthcare > Mylan Inc. (MYL)

The Mylan $MYL Chart Pattern Suggests Lower Ahead

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
ITMS Member Profile
Member Level 
Followed By 45
Posts 1,500
Boards Moderated 1
Alias Born 10/13/09
160x600 placeholder
Mylan Finalizes Previously Disclosed Settlement with U.S. Securities and Exchange Commission PR Newswire (US) - 9/27/2019 10:25:00 AM
Mylan Expands Oncology Portfolio with Launch of Generic Faslodex® Injection, a Treatment for Advanced Breast Cancer PR Newswire (US) - 9/17/2019 9:30:00 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 9/3/2019 9:56:01 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/19/2019 7:30:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/15/2019 6:31:23 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 8/6/2019 4:47:29 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 8/6/2019 4:17:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/5/2019 8:01:23 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/2/2019 6:48:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/2/2019 6:31:20 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 7/31/2019 6:09:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/30/2019 5:30:42 PM
Mylan Deal Caps Pfizer CEO's Remake -- WSJ Dow Jones News - 7/30/2019 3:02:00 AM
WeissLaw LLP Investigates Mylan N.V. PR Newswire (US) - 7/29/2019 8:01:00 PM
Mylan Deal Furthers Pfizer CEO's Bet on Patent-Protected Drugs Dow Jones News - 7/29/2019 6:13:00 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 7/29/2019 5:02:47 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/29/2019 4:17:58 PM
Pfizer to Merge Off-Patent Drug Business With Mylan -- 4th Update Dow Jones News - 7/29/2019 1:52:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/29/2019 12:04:04 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 7/29/2019 12:01:48 PM
Stocks to Watch: Mylan, Merck, Booz Allen, Cooper Tire, Mohawk Industries and More Dow Jones News - 7/29/2019 9:47:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/29/2019 6:57:08 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 7/29/2019 6:55:28 AM
Mylan & Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill th... Business Wire - 7/29/2019 6:45:00 AM
Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill ... PR Newswire (US) - 7/29/2019 6:45:00 AM
ITMS Member Level  Tuesday, 07/17/18 12:23:37 PM
Re: None
Post # of 152 
The Mylan $MYL Chart Pattern Suggests Lower Ahead

Mylan NV (NASDAQ:MYL) is a leading developer of branded and generic drugs. The stock has been slumping since peaking in late January 2018 at $46.72 a share. Since that high pivot, the stock has fallen by more than 10.0 points and is now trading at $36.33 a share. The current daily chart pattern is forming a bearish consolidation pattern which indicates lower share prices ahead. Traders and investors should now watch for major support around the $34.50 area. This support level is where MYL broke out in October 2017 and should be defended again when retested.





Nicholas Santiago
InTheMoneyStocks

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist